CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of CKD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
6125 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C02101 | BRD-K14590126 | farnesyl-thiosalicylic-acid-amide | HRAS | Ras GTPase inhibitor | Details | |
C02102 | BRD-A49622760 | faropenem | lactamase inhibitor | Details | ||
C02103 | BRD-K59045783 | faropenem-medoxomil | lactamase inhibitor | Details | ||
C02104 | BRD-K76617868 | fasudil | PKIA|PRKACA|ROCK1|ROCK2 | rho associated kinase inhibitor | Details | |
C02105 | BRD-K04264130 | favipiravir | RNA polymerase inhibitor | Details | ||
C02106 | BRD-A10991937 | FCE-22250 | DNA directed DNA polymerase inhibitor | Details | ||
C02107 | BRD-K18157228 | fdcyd | DNA methyltransferase inhibitor | Details | ||
C02108 | BRD-K48367671 | febuxostat | XDH | xanthine oxidase inhibitor | Details | |
C02109 | BRD-K99107520 | felbamate | GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B | glutamate receptor antagonist | Details | |
C02110 | BRD-K91740057 | felbinac | CTSL | cyclooxygenase inhibitor | Details | |
C02111 | BRD-K26404903 | felbinac-ethyl | PTGS1|PTGS2 | cyclooxygenase inhibitor | Details | |
C02112 | BRD-A30815329 | felodipine | CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2|CALM1|CFTR|NR3C2|PDE1A|PDE1B|TNNC1|TNNC2 | calcium channel blocker | Details | |
C02113 | BRD-K08791496 | fenaclon | Details | |||
C02114 | BRD-K51318897 | fenbendazole | TUBB | tubulin polymerization inhibitor | Details | |
C02115 | BRD-K12513978 | fenbufen | PTGS1|PTGS2 | cyclooxygenase inhibitor | Details | |
C02116 | BRD-A81615860 | fenclonine-(+/-) | PAH|TPH1|TPH2 | tryptophan hydroxylase inhibitor | Details | |
C02117 | BRD-A71033472 | fendiline | HTR2B | calcium channel blocker | Details | |
C02118 | BRD-A66920069 | fenigam | GABBR1|GABBR2 | benzodiazepine receptor agonist | Details | |
C02119 | BRD-A66284731 | fenipentol | choleretic agent | Details | ||
C02120 | BRD-K41160163 | fenobam | GRM5 | glutamate receptor antagonist | Details | |
C02121 | BRD-K50388907 | fenofibrate | MMP25|PPARA | PPAR receptor agonist | Details | |
C02122 | BRD-K30213273 | fenofibric-acid | CLCN1|PPARA | cytochrome P450 inhibitor | Details | |
C02123 | BRD-A50684349 | fenoldopam | ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD4|DRD5 | dopamine receptor agonist | Details | |
C02124 | BRD-A81129465 | fenoprofen | PTGS1|PTGS2|SLC5A8 | prostaglandin inhibitor | Details | |
C02125 | BRD-A97104540 | fenoterol | ADRB1|ADRB2|ADRB3 | adrenergic receptor agonist | Details | |
C02126 | BRD-K77564118 | fenoverine | acetylcholine receptor antagonist | Details | ||
C02127 | BRD-K44777569 | fenoxaprop-p-ethyl | NOS2|NOS3 | Details | ||
C02128 | BRD-K89085489 | fenretinide | RARA | apoptosis stimulant; retinoid receptor agonist | Details | |
C02129 | BRD-K26739552 | fenspiride | bronchodilator | Details | ||
C02130 | BRD-K67217586 | fenthion | cholinesterase inhibitor | Details | ||
C02131 | BRD-K16077845 | fentiazac | PTGS1|PTGS2 | cyclooxygenase inhibitor | Details | |
C02132 | BRD-A33697453 | fenticonazole | bacterial cell wall synthesis inhibitor | Details | ||
C02133 | BRD-K61642990 | FERb-033 | ERBB2 | EGFR inhibitor | Details | |
C02134 | BRD-K97375133 | ferrostatin-1 | ferroptosis inhibitor | Details | ||
C02135 | BRD-K66295376 | ferulic-acid | CA1|CA12|CA14|CA2|CA4|CA6|CA9 | antioxidant | Details | |
C02136 | BRD-K46731503 | fesoterodine | CHRM1|CHRM2|CHRM3|CHRM4|CHRM5 | acetylcholine receptor antagonist | Details | |
C02137 | BRD-K08864679 | fexaramine | NR1H4 | FXR agonist | Details | |
C02138 | BRD-K37069697 | fexinidazole | Details | |||
C02139 | BRD-A73368467 | fexofenadine | HRH1 | histamine receptor antagonist | Details | |
C02140 | BRD-K56807945 | FG-2216 | EGLN1|EGLN2|HIF1A | hypoxia inducible factor prolyl hydroxylase inhibitor | Details | |
C02141 | BRD-K14385366 | FG-4592 | EGLN2 | hypoxia inducible factor prolyl hydroxylase inhibitor | Details | |
C02142 | BRD-K61951118 | FG-7142 | GABA benzodiazepine site receptor inverse agonist | Details | ||
C02143 | BRD-K09778810 | FGIN-1-27 | TSPO | inositol monophosphatase inhibitor | Details | |
C02144 | BRD-K66093087 | FGIN-1-43 | TSPO | benzodiazepine receptor agonist | Details | |
C02145 | BRD-K48112880 | FH-535 | PPARD|PPARG | PPAR receptor antagonist; WNT signaling inhibitor | Details | |
C02146 | BRD-K44777625 | FH1 | hepatocyte function enhancer | Details | ||
C02147 | BRD-K07160047 | fiacitabine | DNA synthesis inhibitor | Details | ||
C02148 | BRD-A63752151 | fidarestat | AKR1B1 | aldose reductase inhibitor | Details | |
C02149 | BRD-K57371763 | fidaxomicin | RNA polymerase inhibitor | Details | ||
C02150 | BRD-K37379014 | filanesib | KIF11 | kinesin inhibitor; kinesin-like spindle protein inhibitor | Details | |
C02151 | BRD-K16803204 | filgotinib | JAK1|JAK2|JAK3|TYK2 | JAK inhibitor | Details | |
C02152 | BRD-K21586122 | fimasartan | AGTR1 | angiotensin receptor antagonist | Details | |
C02153 | BRD-K98384930 | finafloxacin | bacterial DNA gyrase inhibitor | Details | ||
C02154 | BRD-K01095011 | finasteride | AKR1D1|SRD5A1|SRD5A2 | 5 alpha reductase inhibitor | Details | |
C02155 | BRD-K88025533 | fingolimod | S1PR1|S1PR5 | immunosuppressant; sphingosine phosphate receptor agonist | Details | |
C02156 | BRD-K37688416 | fipexide | psychoactive drug | Details | ||
C02157 | BRD-K61560897 | FIPI | PLD1|PLD2 | phospholipase inhibitor | Details | |
C02158 | BRD-A50675702 | fipronil | chloride channel blocker; GABA gated chloride channel blocker | Details | ||
C02159 | BRD-K17513304 | firategrast | ITGA4 | integrin antagonist | Details | |
C02160 | BRD-K09090523 | firocoxib | PTGS2 | cyclooxygenase inhibitor | Details | |
C02161 | BRD-K31836715 | fisetin | CDK6|FASN | Aurora kinase inhibitor | Details | |
C02162 | BRD-K17896185 | FIT | OPRD1 | opioid receptor agonist | Details | |
C02163 | BRD-A01907367 | FK-33-824 | OPRM1 | opioid receptor agonist | Details | |
C02164 | BRD-K38350380 | FK-3311 | PTGS2 | cyclooxygenase inhibitor | Details | |
C02165 | BRD-K58550667 | FK-866 | NAMPT | niacinamide phosphoribosyltransferase inhibitor | Details | |
C02166 | BRD-K83508485 | FK-888 | TACR1|TACR2 | tachykinin antagonist | Details | |
C02167 | BRD-K80607346 | FK-962 | somatostatin receptor agonist | Details | ||
C02168 | BRD-A86545589 | flavin-adenine-dinucleotide | ACAD8|ACADM|ACADS|ACOX1|AIFM1|CYB5R1|CYB5R3|DAO|DLD|DPYD|ERO1LB|FDXR|GCDH|GFER|GSR|IL4I1|IVD|MAOA|MAOB|NOS1|NQO1|NQO2|POR|TXNRD1|XDH | Details | ||
C02169 | BRD-K47639036 | flavoxate | CHRM1|CHRM2 | acetylcholine receptor antagonist | Details | |
C02170 | BRD-A09472452 | flecainide | KCNA5|KCNA7|SCN4A|SCN5A | sodium channel blocker | Details | |
C02171 | BRD-K61717546 | fleroxacin | topoisomerase inhibitor | Details | ||
C02172 | BRD-A44500574 | FLI-06 | notch signaling inhibitor | Details | ||
C02173 | BRD-K33637378 | flibanserin | DRD4|HTR1A|HTR2A | serotonin receptor agonist | Details | |
C02174 | BRD-K56740996 | flindokalner | KCNMA1|KCNN4|KCNQ2|KCNQ4|KCNQ5 | potassium channel agonist | Details | |
C02175 | BRD-A23418262 | floctafenine | PTGS1|PTGS2 | cyclooxygenase inhibitor | Details | |
C02176 | BRD-K43383936 | flopropione | HTR1A | serotonin receptor antagonist | Details | |
C02177 | BRD-A30886737 | florfenicol | protein synthesis inhibitor | Details | ||
C02178 | BRD-A79643124 | flosequinan | phosphodiesterase inhibitor | Details | ||
C02179 | BRD-A03757454 | floxuridine | TYMS | DNA synthesis inhibitor | Details | |
C02180 | BRD-K86003836 | flubendazole | TUBB | tubulin polymerization inhibitor | Details | |
C02181 | BRD-K27871792 | flucloxacillin | bacterial cell wall synthesis inhibitor | Details | ||
C02182 | BRD-K05977355 | fluconazole | CYP51A1 | sterol demethylase inhibitor | Details | |
C02183 | BRD-K82143716 | flucytosine | DNMT1 | other antifungal | Details | |
C02184 | BRD-K66788707 | fludarabine | ADA|RRM1|RRM2 | ribonucleotide reductase inhibitor | Details | |
C02185 | BRD-K71106091 | fludarabine-phosphate | DCK|POLA1|POLD1|POLE|RRM1|RRM2|RRM2B | ribonucleotide reductase inhibitor | Details | |
C02186 | BRD-K06408664 | fludrocortisone-acetate | AR|NR3C1|NR3C2 | Details | ||
C02187 | BRD-A49765801 | fludroxycortide | NR3C1|SERPINA6 | glucocorticoid receptor agonist | Details | |
C02188 | BRD-K44067360 | flufenamic-acid | AKR1C3|ANO1|AR|GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|PANX1|PANX2|PANX3|PKD2L1|PTGS1|PTGS2|TRPC5|TRPM2|TRPM5 | chloride channel blocker | Details | |
C02189 | BRD-K68870568 | flumatinib | ABL1|PDGFRB | Bcr-Abl kinase inhibitor | Details | |
C02190 | BRD-K98769987 | flumazenil | GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ | benzodiazepine receptor antagonist | Details | |
C02191 | BRD-A44181516 | flumecinol | Details | |||
C02192 | BRD-A69777949 | flumequine | topoisomerase inhibitor | Details | ||
C02193 | BRD-K61496577 | flumethasone | NR3C1|PLA2G1B | glucocorticoid receptor agonist | Details | |
C02194 | BRD-A50064262 | flumethasone-pivalate | NR3C1|SERPINA6 | glucocorticoid receptor agonist | Details | |
C02195 | BRD-A43518428 | flumexadol | Details | |||
C02196 | BRD-K29582677 | flunarizine | CACNA1G|CACNA1H|CACNA1I|CALM1|HRH1 | calcium channel blocker | Details | |
C02197 | BRD-A65449987 | flunisolide | NR3C1 | cytochrome P450 inhibitor | Details | |
C02198 | BRD-K99984802 | flunixin-meglumin | prostanoid receptor antagonist | Details | ||
C02199 | BRD-K94353609 | fluocinolone-acetonide | NR3C1|SERPINA6 | glucocorticoid receptor agonist | Details | |
C02200 | BRD-K57886322 | fluocinonide | NR3C1|SERPINA6|SMO | glucocorticoid receptor agonist | Details |